LATEST

• ORGANIZATION JPMA Launches Task Force on AI and Open Innovation Challenges: IP Chief
  September 18, 2025

• REGULATORY FIRM Calls for Pricing Overhaul to Reflect Unique Benefits of Regenerative Therapies
  September 18, 2025

• REGULATORY FPMAJ Urges Blanket Drug Price Hikes to Offset Inflation: FY2026 Reform Talks
  September 18, 2025

• BUSINESS Nihon Chouzai Tender Offer Completed, Set to Delist under Advantage Partners
  September 18, 2025

• REGULATORY MHLW Orders Label Revision for Imdelltra over CRS Risks
  September 18, 2025

• BUSINESS RaQualia’s Reflux Therapy Tegoprazan Debuts in India
  September 18, 2025

• BUSINESS Eisai’s Etalanetug Snags FDA Fast Track Designation
  September 18, 2025

• BUSINESS Daito Wins China Approval for Celecoxib, 2nd Generic in Market
  September 18, 2025

• REGULATORY MHLW Gathers 140 Proposals for New Elective Care Items: Chuikyo
  September 18, 2025

• REGULATORY J&J’s Subcutaneous Rybrevant Faces Delay in Japan Approval Process
  September 17, 2025

• BUSINESS Alnylam Sees Japan Business Doubling as Amvuttra Expands into ATTR-CM
  September 17, 2025

• ORGANIZATION JPMA to Broaden Base of Biopharma Talent through On-Site Training: Committee Chair
  September 17, 2025

• BUSINESS Kyorin/aTyr’s Efzofitimod Misses Primary Goal in Global PIII Trial
  September 17, 2025

• BUSINESS Mitsubishi, J&J to End Stelara Co-Promotion in Japan at Year-End
  September 17, 2025

• BUSINESS ASKA Presses Dalton Again for Stake Plan Details after Public Statement
  September 17, 2025

• REGULATORY Japan Confirms First Case of Mpox Clade 1b
  September 17, 2025

• BUSINESS Daiichi Bags FDA Breakthrough Therapy Status for Anti-CDH6 ADC
  September 17, 2025

• REGULATORY MHLW Withdraws Sakigake Tag for Takeda’s TAK-925
  September 17, 2025

ページ

• « 先頭
• ‹ Prev
• …
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19